These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 527887)
21. Evaluation of a rapid method for determination of total urinary estrogens in morning samples from normally menstruating women. Fleetwood L; Shu-rong Z; Eneroth P; Landgren BM Contraception; 1983 Apr; 27(4):329-38. PubMed ID: 6851563 [TBL] [Abstract][Full Text] [Related]
22. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin. Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063 [TBL] [Abstract][Full Text] [Related]
23. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation. Croxatto HB; Salvatierra AM; Romero C; Spitz IM J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656 [TBL] [Abstract][Full Text] [Related]
24. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle. Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601 [TBL] [Abstract][Full Text] [Related]
25. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human. Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781 [TBL] [Abstract][Full Text] [Related]
26. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017 [TBL] [Abstract][Full Text] [Related]
27. A study of peroxidase levels in human cervical mucus as an index of ovulation. Shindler JS; Haworth K; Axon A; Bardsley WG; Tindall VR; Laing I J Reprod Fertil; 1977 Nov; 51(2):413-7. PubMed ID: 592293 [TBL] [Abstract][Full Text] [Related]
28. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle. Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481 [TBL] [Abstract][Full Text] [Related]
30. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach. Lemay A; Faure N J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711 [TBL] [Abstract][Full Text] [Related]
31. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550 [TBL] [Abstract][Full Text] [Related]
32. Natural family planning indicators of ovulation. Gross BA Clin Reprod Fertil; 1987 Jun; 5(3):91-117. PubMed ID: 3322540 [TBL] [Abstract][Full Text] [Related]
34. Temporal relationship and reliability of the clinical, hormonal, and ultrasonographic indices of ovulation in infertile women. Luciano AA; Peluso J; Koch EI; Maier D; Kuslis S; Davison E Obstet Gynecol; 1990 Mar; 75(3 Pt 1):412-6. PubMed ID: 2406661 [TBL] [Abstract][Full Text] [Related]
35. An evaluation of teaching cervical mucus symptoms to ovulating infertile women. Graham FM; Gosling L; France JT Aust N Z J Obstet Gynaecol; 1983 Nov; 23(4):226-30. PubMed ID: 6585197 [TBL] [Abstract][Full Text] [Related]
36. Lactate dehydrogenase in human cervical mucus: correlation with ovulation, influence of ovarian steroid hormones, and isozyme pattern. Takehisa T Fertil Steril; 1980 Feb; 33(2):135-40. PubMed ID: 7353690 [TBL] [Abstract][Full Text] [Related]
37. 'Patient failure' as a reliability model for the 'minipill': a clinical study. Nummi S Curr Med Res Opin; 1978; 5(5):406-11. PubMed ID: 350492 [TBL] [Abstract][Full Text] [Related]
38. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception. Balogh A; Ditrói F; Lampé LG Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699 [TBL] [Abstract][Full Text] [Related]
39. [Blockade of LH and FSH peaks by low doses of exogenous progesterone in the human female (author's transl)]. Netter A; Gorins A; Thomas K; Cohen M; Joubinaux J Ann Endocrinol (Paris); 1973; 34(4):430-5. PubMed ID: 4779738 [TBL] [Abstract][Full Text] [Related]
40. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]